Abstract
Permanent prostatic stents are an option for patients in whom a transurethral procedure is prohibitive, although complications involving stent migration/removal complicate widespread use. Temporary stents in the form of retrievable stents have growing applications following procedures such as brachytherapy or transurethral thermotherapy, where there is transient prostatic edema. Careful patient selection and follow-up is paramount within this population, regardless of the duration of the stent.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Oelke M, Bachmann A, Descazeaud A, Emberton M, Gravas S, Michel MC, et al. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol. 2013;64(1):118–40. PubMed PMID: 23541338. Epub 2013/04/02. Eng.
Anjum MI, Chari R, Shetty A, Keen M, Palmer JH. Long-term clinical results and quality of life after insertion of a self-expanding flexible endourethral prosthesis. Br J Urol. 1997;80(6):885–8. PubMed PMID: 9439402, Epub 1998/01/24. eng.
Fabian KM. The intra-prostatic “partial catheter” (urological spiral) (author’s transl)]. Urologe A. 1980;19(4):236–8. PubMed PMID: 7414771. Epub 1980/07/01. Der Intraprostatische “Partielle Katheter” (Urologische Spirale). ger.
Oesterling JE, Kaplan SA, Epstein HB, Defalco AJ, Reddy PK, Chancellor MB. The North American experience with the UroLume endoprosthesis as a treatment for benign prostatic hyperplasia: long-term results. The North American UroLume Study Group. Urology. 1994;44(3):353–62. PubMed PMID: 7521091, Epub 1994/09/01. eng.
Juma S, Niku SD, Brodak PP, Joseph AC. Urolume urethral wallstent in the treatment of detrusor sphincter dyssynergia. Paraplegia. 1994;32(9):616–21. PubMed PMID: 7997341. Epub 1994/09/01. eng.
Mebust WK, Holtgrewe HL, Cockett AT, Peters PC. Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol. 1989;141(2):243–7.
Madersbacher S, Marberger M. Is transurethral resection of the prostate still justified? BJU Int. 1999;83(3):227–37. PubMed PMID: 10233485. Epub 1999/05/08. eng.
Ahyai SA, Gilling P, Kaplan SA, Kuntz RM, Madersbacher S, Montorsi F, et al. Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol. 2010;58(3):384–97. PubMed PMID: 20825758. Epub 2010/09/10. eng.
Masood S, Djaladat H, Kouriefs C, Keen M, Palmer JH. The 12-year outcome analysis of an endourethral wallstent for treating benign prostatic hyperplasia. BJU Int. 2004;94(9):1271–4. PubMed PMID: 15610103. Epub 2004/12/22. eng.
Vanderbrink BA, Rastinehad AR, Badlani GH. Prostatic stents for the treatment of benign prostatic hyperplasia. Curr Opin Urol. 2007;17(1):1–6. PubMed PMID: 17143103. Epub 2006/12/05. eng.
Armitage JN, Cathcart PJ, Rashidian A, De Nigris E, Emberton M, van der Meulen JH. Epithelializing stent for benign prostatic hyperplasia: a systematic review of the literature. J Urol. 2007;177(5):1619–24. PubMed PMID: 17437773. Epub 2007/04/18. eng.
van Dijk MM, Mochtar CA, Wijkstra H, Laguna MP, de la Rosette JJ. The bell-shaped nitinol prostatic stent in the treatment of lower urinary tract symptoms: experience in 108 patients. Eur Urol. 2006;49(2):353–9. PubMed PMID: 16426738. Epub 2006/01/24. eng.
van Dijk MM, Mochtar CA, Wijkstra H, Laguna MP, de la Rosette JJ. Hourglass-shaped nitinol prostatic stent in treatment of patients with lower urinary tract symptoms due to bladder outlet obstruction. Urology. 2005;66(4):845–9. PubMed PMID: 16230150. Epub 2005/10/19. eng.
Williams G, White R. Experience with the Memotherm permanently implanted prostatic stent. Br J Urol. 1995;76(3):337–40. PubMed PMID: 7551842.
Gesenberg A, Sintermann R. Management of benign prostatic hyperplasia in high risk patients: long-term experience with the Memotherm stent. J Urol. 1998;160(1):72–6. PubMed PMID: 9628608.
Ogiste JS, Cooper K, Kaplan SA. Are stents still a useful therapy for benign prostatic hyperplasia? Curr Opin Urol. 2003;13(1):51–7. PubMed PMID: 12490816. Epub 2002/12/20. eng.
Shah DK, Kapoor R, Badlani GH. Experience with urethral stent explantation. J Urol. 2003;169(4):1398–400. PubMed PMID: 12629371. Epub 2003/03/12. eng.
Wilson TS, Lemack GE, Dmochowski RR. UroLume stents: lessons learned. J Urol. 2002;167(6):2477–80. PubMed PMID: 11992061. Epub 2002/05/07. eng.
Thomas PJ, Britton JP, Harrison NW. The Prostakath stent: four years’ experience. Br J Urol. 1993;71(4):430–2. PubMed PMID: 7684649.
Poulsen AL, Schou J, Ovesen H, Nordling J. Memokath: a second generation of intraprostatic spirals. Br J Urol. 1993;72(3):331–4. PubMed PMID: 7693295. Epub 1993/09/01. eng.
Armitage JN, Rashidian A, Cathcart PJ, Emberton M, van der Meulen JH. The thermo-expandable metallic stent for managing benign prostatic hyperplasia: a systematic review. BJU Int. 2006;98(4):806–10. PubMed PMID: 16879446. Epub 2006/08/02. eng.
Lee G, Marathe S, Sabbagh S, Crisp J. Thermo-expandable intra-prostatic stent in the treatment of acute urinary retention in elderly patients with significant co-morbidities. Int Urol Nephrol. 2005;37(3):501–4. PubMed PMID: 16307329. Epub 2005/11/25. eng.
Barber NJ, Roodhouse AJ, Rathenborg P, Nordling J, Ellis BW. Ease of removal of thermo-expandable prostate stents. BJU Int. 2005;96(4):578–80. PubMed PMID: 16104913. Epub 2005/08/18. eng.
Corica AP, Larson BT, Sagaz A, Corica AG, Larson TR. A novel temporary prostatic stent for the relief of prostatic urethral obstruction. BJU Int. 2004;93(3):346–8. PubMed PMID: 14764134. Epub 2004/02/07. eng.
Henderson A, Laing RW, Langley SE. A Spanner in the works: the use of a new temporary urethral stent to relieve bladder outflow obstruction after prostate brachytherapy. Brachytherapy. 2002;1(4):211–8. PubMed PMID: 15062169. Epub 2004/04/06. eng.
Dineen MK, Shore ND, Lumerman JH, Saslawsky MJ, Corica AP. Use of a temporary prostatic stent after transurethral microwave thermotherapy reduced voiding symptoms and bother without exacerbating irritative symptoms. Urology. 2008;71(5):873–7. PubMed PMID: 18374395. Epub 2008/04/01. eng.
Kemppainen E, Talja M, Riihela M, Pohjonen T, Tormala P, Alfthan O. A bioresorbable urethral stent. An experimental study. Urol Res. 1993;21(3):235–8. PubMed PMID: 8342257.
Petas A, Talja M, Tammela TL, Taari K, Valimaa T, Tormala P. The biodegradable self-reinforced poly-DL-lactic acid spiral stent compared with a suprapubic catheter in the treatment of post-operative urinary retention after visual laser ablation of the prostate. Br J Urol. 1997;80(3):439–43. PubMed PMID: 9313664.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Badalato, G.M., Rutman, M.P. (2015). Prostatic Stents. In: Chughtai, B., Te, A., Kaplan, S. (eds) Treatment of Benign Prostatic Hyperplasia: Modern Alternative to Transurethral Resection of the Prostate. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1587-3_19
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1587-3_19
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-1586-6
Online ISBN: 978-1-4939-1587-3
eBook Packages: MedicineMedicine (R0)